NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients whose nasopharyngeal cancer returns
Disease control Not yet recruitingThis study is testing a new combination treatment for people whose nasopharyngeal cancer has returned in the original area after initial treatment. It will enroll 25 patients to receive an initial phase of two drugs (MRG003 and Tislelizumab) followed by a year of maintenance ther…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Three-Drug attack on tough head & neck cancer
Disease control Not yet recruitingThis study is testing a combination of three drugs (chidamide, toripalimab, and anlotinib) for people with advanced nasopharyngeal cancer that has come back or spread after at least one prior treatment. The main goals are to find the safest dose of chidamide in this combo and to …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Cancer treatment crossroads: which path works better when first drugs fail?
Disease control Not yet recruitingThis study aims to find out which treatment approach works better for patients with advanced nasopharyngeal cancer when their initial chemotherapy doesn't shrink the tumor enough. Researchers will observe 223 patients who receive either additional chemotherapy followed by radiati…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Scientists hunt for hidden cancer clues in patient blood and tissue
Knowledge-focused Not yet recruitingThis study aims to discover molecular markers in the blood and tumor tissue of patients with nasopharyngeal cancer. Researchers will collect samples from 60 patients before, during, and after their standard chemotherapy and radiation treatment. The goal is to find biological clue…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC